| Literature DB >> 31668903 |
Gonçalo Sousa Pinto1, Lina Bader2, Kristina Billberg3, Deirdre Criddle4, Catherine Duggan2, Luna El Bizri5, Manjiri Gharat6, Michael D Hogue7, Isabel Jacinto8, Yetunde Oyeneyin9, Ying Zhou10, Anna Laven11.
Abstract
According to the World Health Organization (WHO), more than 36 million people die annually from non-communicable diseases (NCDs), representing over 60% of deaths worldwide, 15 million of which occur before the age of 70 years. Prevention and control of NCDs and their risk factors require interventions that are therapeutically cost-effective, affordable by the patient and/or health systems and feasible, based upon local resources. This commentary paper sets a basis of global evidence to advocate, nationally and internationally, for an expanded role for pharmacists in NCD management by compiling best practices and examples. It encourages pharmacists around the world to act upon NCDs, from prevention and screening activities, to patient referral when appropriate, and to pharmacist-led, patient-centred NCD management to improve outcomes and quality of life. Priority NCDs fall into four areas: cardiovascular diseases, diabetes, asthma/chronic obstructive pulmonary disease and cancer. Building on the key roles they already play as primary healthcare professionals in the community, pharmacists can provide focused interventions, specialised counselling and care coordination, improving patient engagement to achieve better outcomes in the global fight against NCDs.Entities:
Keywords: Asthma; COPD; Cancer; Cardiovascular; Community; Diabetes; Disease management; NCDs; Non-communicable diseases; Pharmaceutical care; Pharmacists; Pharmacy; Prevention; Primary health care; Referral; Screening; Treatment optimisation
Mesh:
Year: 2019 PMID: 31668903 DOI: 10.1016/j.sapharm.2019.10.008
Source DB: PubMed Journal: Res Social Adm Pharm ISSN: 1551-7411